The Clinical Efficacy of Dabrafenib Plus Trametinib Combination Treatment in Stage III/â…£ BRAF-Mutated Melanoma

Zhao Hongbing, Feng Ting Ting, Li Xiao Rui and Zhang Xifeng
Additional contact information
Li Xiao Rui: Department of Oncology, China
Zhang Xifeng: Shang Qiu Medical School, China

Biomedical Journal of Scientific & Technical Research, 2018, vol. 12, issue 1, 9004-9005

Abstract: The morbidity of cutaneous melanoma has continued to increase in recent years. Patients with stage III disease are at higher risk for recurrence after locoregional resection and many will ultimately die from metastatic melanoma...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Dabrafenib; Trametinib; Braf; Mek; Mutant; Melanoma (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.002205.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.002205.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:12:y:2018:i:1:p:9004-9005

DOI: 10.26717/BJSTR.2018.12.002205

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().